Introduction Grand Pharma (China) Co., Ltd. originated as Wuhan Pharmaceutical Factory, established in 1939 within the revolutionary base of the Taihang Mountains. In 2002, it underwent an asset reorganization with the China Grand Enterprise Inc. Grand Pharma is a publicly traded company in China that is noteworthy for its focus on both innovative pharmaceuticals and high-end medical devices. Through years of growth and accumulation of expertise, the company has established comprehensive coverage in the domains of cardiovascular and cerebrovascular diseases, oncology, and respiratory disorders. |